Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants

Clinical trial NCT06690515 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06690515
Sponsor: PT Bio Farma
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Vaccine Adverse Reaction Vaccine Reaction

Start date: 2025-03-01
Primary completion: 2025-10-31
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.